First Ascent Biomedical

Join Us for The Role of AI from Diagnosis to Treatment for Childhood Cancer Webinar When: April 17, 2025 from 12:00 PM - 1:00 PM EST Join CAC2 for an insightful webinar featuring leading experts who will discuss the role of AI in transforming diagnosis, treatment, and patient advocacy in childhood cancer. Featured Speakers: BrandiLee Sawyer – Patient Advocate at @First Ascent Biomedical Dr. Adam Resnick – Director, Center for Data Driven Discovery in Biomedicine at Children's Hospital of Philadelphia , Children's Brain Tumor Network Jesse Tetreault – Senior Solutions Architect, NVIDIA Don’t miss this opportunity to learn how AI and precision medicine are shaping the future of pediatric oncology. Register today! https://lnkd.in/gwG84D7s

“Fighting Cancer is never done in a silo; it takes a committed team, and the Erie community embodies that spirit of collaboration,” said Jim Foote, founder and chief executive officer of First Ascent Biomedical Today was a huge milestone for Gannon University. We announced an important partnership with First Ascent and AHN Saint Vincent Hospital that will not only impact our students and Gannon family but will impact the lives of many Erie County residents. First Ascent features a first-in-kind A.I.-driven drug prediction platform that integrates DNA/RNA sequencing, mutation analysis, and drug sensitivity on cancer cells. This platform delivers a highly personalized, actionable treatment plan to a patient’s physician in an average of 10 days. Results from initial studies indicated the platform has significantly extended life in study subjects. First Ascent intends to use a 3,000-square-foot lab on the fourth floor of I-HACK and another 2,000 square feet of space for offices. It expects to handle 20,000 patients a year through the Gannon lab. In addition, Saint Vincent Hospital plans to use a second 3,000-square-foot lab on the fourth floor of I-HACK to augment its longstanding lab at Saint Vincent Hospital and to expand the hospital’s existing medical laboratory science program. ECGRA - Erie County Gaming Revenue Authority awarded its largest grant ever to a single project to invest in this partnership. The Josh Shapiro Administration (Pennsylvania Department of Community & Economic Development) is investing more than $1.7 million to support this construction, and the Lutheran Foundation for Long-Term Living is contributing $2 million. This is all possible thanks to the relationships formed via the Erie Regional Chamber and Growth Partnership. Read more here: https://bit.ly/41WihVn

Innovation in Action at the #CancerX Accelerator Moffitt Innovation Summit! What an inspiring and productive day at our 2nd Annual?CancerX Accelerator Moffitt Innovation Summit, the official in-person kickoff event of the 2025 CancerX Accelerator program. Yesterday brought together our?14 selected oncology startups?and?Champion Organizations?for a deep dive into the future of scalable digital oncology by working together across healthcare sectors (from health systems to pharma to payers to VCs to startups).? ? The day was packed with highlights, including: An Executive breakfast with our Accelerator Champion organizations including CancerX Steering Committee members Ashita Batavia, MD, MS and?Xavier Avat, moderated by CancerX Lead,?Kamal Jethwani. A powerful?patient keynote?by Dr.?Vondalyn Wright, emphasizing the importance of considering potential barriers to digital solution adoption often faced.? Insightful?panels?featuring Moffitt leaders like?John L. Cleveland, PhD, PhD,?Kelley Gonzalvo, DNP, RN, CCRN-K,?Dana Rollison, PhD,?Gilmer Valdes,?Alexander Anderson, Roderick Harris, MBA, Roger Li, Matt Bednar, Randa Perkins, MD, MBA, FAMIA, and Xuefeng Wang discussing Moffitt's innovation strategy, navigating the health system as a startup, and the transformative power of big data, AI, and integrated mathematical modeling. Dynamic?Startup Showcases?featuring cutting-edge solutions from companies like?Encapsulate,?We Are Here,?Dyania Health,?First Ascent Biomedical, and many more, expertly hosted by?Grace Cordovano, PhD, BCPA. An insightful?Alumni Fireside Chat?with?Ognjen (Oggie) Nikolic?and?Naresh Ramarajan?sharing perspectives on how to make the most of the CancerX Accelerator program based on their experiences this past year.? And crucial?afternoon working sessions?that fostered direct collaboration between startups and multiple champion organizations - learning from one another in the same room to explore pilot project and strategic partnership opportunities. ? The energy and commitment to?accelerating digital solutions?to?reduce cancer mortality?and?improve patient experience?were truly remarkable. Thank you to everyone who participated and contributed to the success of this summit! It was truly an honor to serve as your Master of Ceremonies. ? Let's continue to drive innovation forward TOGETHER. Learn more at?www.cancerx.health?and join us as a member, we are just getting started! ? #CancerX #DigitalOncology #InnovationSummit #HealthTech #Collaboration #CancerResearch #PatientExperience? Advocate Health Johnson & Johnson Dana-Farber Cancer Institute Memorial Sloan Kettering Cancer Center KidsX Oncology Ventures Innsena Elevance Health Lindsay Deneault Rick Peng Mary T. Benjamin Tingey Mellisa Wheeler Daniel Phillips Sanchez Nandita Kotwani Jot Chahal Kevin Platé EdS MBA Jon Moore MS, JD, HCISPP S. Ben Freeberg ?

Listen to Jim Foote, CEO of First Ascent Biomedical discuss the power of functional precision medicine (FPM) in personalizing cancer treatment, enabling oncologists to go beyond today's standard of care. Precision Therapy and Personalized Medicine in Oncology Webinar Friday, March 14, 2025 Rx Device Consulting, Boston Biotech Advisors, LLC Rakesh Lal, Stephanie Illich Stroll ??

Don't miss the latest in our webinar series on innovations in healthcare. This month's webinar focuses on novel cancer treatment technologies being developed by Theromics Inc. and First Ascent Biomedical. I am very excited to be speaking with Jim Foote (CEO of First Ascent) and Suman Lal (CEO of Theromics) about how their respective companies may offer a game changer in cancer treatment. Register here: https://lnkd.in/gTbKy4Qa

First Ascent Biomedical exemplifies the digital innovation in oncology that CancerX is committed to advancing—where cutting-edge technology meets biological insights to create truly personalized cancer care solutions. This is why CancerX and KidsX are so happy to have them in the 2025 Accelerator! They're trying to revolutionize cancer treatment at the intersection of biology and technology with an innovative precision medicine platform. First Ascent's approach includes proprietary AI algorithms that analyze and match the biopsy pathology results with the most effective drugs for each specific patient, dramatically accelerating the path to effective treatment. We're excited to support First Ascent Biomedical as they work to make precision oncology more accessible and effective! #CancerXAccelerator #PrecisionMedicine #OncologyInnovation #AIinHealthcare #PersonalizedCancerCare #KidsX